Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome
Top Cited Papers
Open Access
- 27 April 2020
- journal article
- research article
- Published by eLife Sciences Publications, Ltd in eLife
Abstract
COVID-19 patients can present with pulmonary edema early in disease. We propose that this is due to a local vascular problem because of activation of bradykinin 1 receptor (B1R) and B2R on endothelial cells in the lungs. SARS-CoV-2 enters the cell via ACE2 that next to its role in RAAS is needed to inactivate des-Arg9 bradykinin, the potent ligand of the B1R. Without ACE2 acting as a guardian to inactivate the ligands of B1R, the lung environment is prone for local vascular leakage leading to angioedema. Here, we hypothesize that a kinin-dependent local lung angioedema via B1R and eventually B2R is an important feature of COVID-19. We propose that blocking the B2R and inhibiting plasma kallikrein activity might have an ameliorating effect on early disease caused by COVID-19 and might prevent acute respiratory distress syndrome (ARDS). In addition, this pathway might indirectly be responsive to anti-inflammatory agents.This publication has 23 references indexed in Scilit:
- Pathophysiology of Bradykinin-Mediated Angioedema: The Role of the Complement SystemPublished by IntechOpen ,2017
- Kinin B1 Receptor Antagonist BI113823 Reduces Acute Lung Injury*Critical Care Medicine, 2015
- An Interaction of Renin-Angiotensin and Kallikrein-Kinin Systems Contributes to Vascular Hypertrophy in Angiotensin II-Induced Hypertension: In Vivo and In Vitro StudiesPLOS ONE, 2014
- Vasopressor meets vasodepressor: The AT1–B2 receptor heterodimerBiochemical Pharmacology, 2014
- Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63Journal of Virology, 2010
- Development of Orally Bioavailable and CNS Penetrant Biphenylaminocyclopropane Carboxamide Bradykinin B1 Receptor AntagonistsJournal of Medicinal Chemistry, 2006
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injuryNature Medicine, 2005
- Angiotensin-converting enzyme 2 protects from severe acute lung failureNature, 2005
- Kinin B1 Receptor Up-Regulation after Lipopolysaccharide Administration: Role of Proinflammatory Cytokines and Neutrophil InfluxThe Journal of Immunology, 2004
- Bioregulation of kinins: kallikreins, kininogens, and kininases.1992